DBXO-1

N/A

Report date: 2026/04/29 20:02:18

Base Information

Drug NameDBXO-1

Drug Alias NameDBXO-1DBXO1

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagersBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionAnti-CD3

TargetsT cell surface glycoprotein CD3

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDeck Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesDeck Bio Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A